START-Events is a prospective, observational, international, multi-center study. The purpose is to collect clinical data that are useful to analyze and to identify the best way to treat acute bleeding or thrombotic events that occur during anticoagulation with DOACs and to describe clinical outcomes both in the short-term and after a 6-month follow-up.
START2 PORTUGAL, is an independent observational prospective cohort, multicenter study, on the history of patients treated with anticoagulant/antithrombotic drugs.
The aims of the study are to provide a better evaluation of efficacy and safety of different treatment options, and to improve our understanding of the risks/benefits of the various drugs by recording and analyzing data from patients observed in real life.
The study has an exclusively observational purpose in order to be the starting point for collaborative clinical studies, enabling their planning and execution; it is not aimed to influence the treatment of the individual patients included in the study.